RxDoctor Payments Data

Angela Merrifield, MD

Family Medicine · Johnson City, TNNPI 1124025408

Payments from drug & device makers

$8,601in general payments, 2019–2025

Across 576 payments — averaging $14.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • AbbVie$1K
  • Amgen$768
  • Novo Nordisk$764
  • Pfizer$652
  • Lilly USA, LLC$581
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$8,601100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,601 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$117,434
Medicare patients
161
Services billed
3,905

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide82$102,357
EliquisApixaban102$73,504
JardianceEmpagliflozin59$62,411
OzempicSemaglutide41$57,058
FarxigaDapagliflozin Propanediol58$41,421
XareltoRivaroxaban23$19,994
EntrestoSacubitril/Valsartan26$18,742
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog34$18,223
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$17,636
MounjaroTirzepatide15$16,259
Bydureon BciseExenatide Microspheres13$10,793
LivaloPitavastatin Calcium16$10,326
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$8,197
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$7,743
Rosuvastatin Calcium602$6,107

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$581$118,61697 claims
PfizerEliquis$652$73,504102 claims
Boehringer IngelheimJardiance, Stiolto Respimat$434$70,60870 claims
Novo NordiskOzempic$764$57,05841 claims
AstraZenecaFarxiga$1,184$41,42158 claims
GSKTrelegy Ellipta, Anoro Ellipta$483$25,37832 claims
Johnson & JohnsonXarelto$65$19,99423 claims
NovartisEntresto$186$18,74226 claims
Kowa Pharmaceuticals America, Inc.Livalo$27$10,32616 claims
AbbVieSynthroid$1,174$3,18348 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Johnson City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →